Sign in
Back
68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia
Journal article   Open access  Peer reviewed

68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia

Diala El-Maouche, Samira M Sadowski, Georgios Z Papadakis, Lori Guthrie, Candice Cottle-Delisle, Roxanne Merkel, Corina Millo, Clara C Chen, Electron Kebebew and Michael T Collins
The journal of clinical endocrinology and metabolism, Vol.101(10), pp.3575-3581
2016-10
DOI: https://doi.org/10.1210/jc.2016-2052
PMCID: PMC5052344
PMID: 27533306

Abstract

Original
Tumor-induced osteomalacia is caused by FGF23-secreting tumors that are notoriously difficult to localize. In this first, prospective study of patients with TIO, we have found that 68 Ga-DOTATATE as a single study is superior to Octreoscan or FDGPET/ CT.
url
https://doi.org/10.1210/jc.2016-2052View
Published (Version of record) Open

Metrics

9 Record Views
89 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.80 Bone Diseases
1.80.348 Primary Hyperparathyroidism
Web Of Science research areas
Endocrinology & Metabolism
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details